Chamber and committees

There is no funding solely allocated to the Respiratory Care Action Plan (RCAP) in 2025-2026. However, a number of the commitments in the Plan are being addressed by work that is part of other Scottish Government strategies– such as the Cleaner Air for Scotland Strategy, Warmer Homes Strategy, and the refreshed Tobacco Action Plan - or by additional funding we have provided to NHS Boards on a broader basis to make improvements that apply regardless of condition. This means it is difficult to break down funding we provide to various areas and organisations that is spent on delivering commitments listed in the RCAP.

For example, we are investing a record £21.7bn in our NHS in Scotland in 2025-2026, this includes £200m to reduce waiting times, which will deliver additional MRI, CT, ultrasound and endoscopy procedures and supports the delivery of the RCAP commitment to improve and simplify access to appropriate diagnostic tests.

I refer the member to the answer to the question S6W-22818 on 23 November 2023. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Table 1 provides information on average gross revenue expenditure in Scotland per child attending pre-school, and per primary and secondary pupil alongside allocations (accounting for teaching and tuition fees funding) per college and university place.

2024-25 figures for Pre-School, Primary and Secondary School will be available after the publication of the 2024-25 Scottish local government finance statistics in February – March 2026.

The Scottish Government do not hold data on Pre-School registrations prior to 2010.

Indicative University and College funding allocations for 2025-26 were published by the Scottish Funding Council (SFC) earlier this month. These include a cash terms increase in teaching funding for colleges, and a cash terms increase to the Main Teaching Grant (and teaching price) for Universities, compared with last year. These indicative figures have not been included in this table as the underlying calculation requires further details, including the number of controlled and non-controlled funded places, which are not yet available to SFC.

Further detail of College and University Indicative Funding Allocations for 2025-26 can be found at:

College Indicative Funding Allocations 2025-26 - Scottish Funding Council

University Indicative Funding Allocations 2025-26 - Scottish Funding Council

Table 1: Average Expenditure Per Place for each Education Level (Cash Terms)

Information on public bodies for which either the Scotish Government or Scottish Parliament are responsible is publicly available on the National Public Bodies Directory Executive non-departmental public bodies - National public bodies: directory - gov.scot.

Each entry on the national directory includes staff numbers and details of Scottish Government funding where the information is held. There is also a link to the respective public body website where details of the public bodies functions and board members can be found.

The Scottish Government’s Respiratory Care Action Plan (RCAP) sets out our priorities from 2021 to 2026 for driving improvement in the prevention, diagnosis, care, treatment and support of people living with respiratory conditions. A number of areas included in the RCAP are broad priorities requiring continuous work rather than finite commitments that can be completed.

We have undertaken action against every area of the Plan.

To give just some examples, significant steps have been taken on preventing respiratory disease with the launch of the Cleaner Air for Scotland Strategy, Warmer Homes Strategy and the refreshed Tobacco Action Plan that have their own specific recommendations and targets, and all of which embed respiratory prevention into wider Scottish Government policy.

In 2024, we published the Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027 that sets out our ambitions for better access to respiratory care. This can be found here --https://www.gov.scot/publications/quality-prescribing-strategy-respiratory-guide-improvement-2024-2027

The Centre for Sustainable Delivery based at the Golden Jubilee National Hospital is developing national patient pathways for respiratory conditions including severe asthma, COPD and sleep apnoea. This work aligns closely with the commitments in the RCAP.

In 2023, the Scottish Government provided Public Health Scotland with funding to undertake a scoping exercise with a view to developing a respiratory audit programme. However, due to current fiscal challenges, it has not yet been possible to progress this work further.

We recognise the importance of having access to meaningful data in relation to respiratory services and we are carefully considering the best way that this can be achieved going forward.

I refer the member to the answer to the question S6W-22819 on 23 November 2023. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Funding Council (SFC) has a statutory duty set out in the Further and Higher Education (Scotland) Act 2005 to secure the coherent provision by the post-16 education bodies (as a whole) of a high quality of fundable further education and fundable higher education.

The Scottish Government does not assess geographical variations in people accessing Scottish Medicines Consortium-approved therapies for advanced or complex Parkinson’s Disease. However, the Centre for Sustainable Delivery are having initial conversations about the potential to undertake Parkinson’s Disease pathway work, which we understand would help to explore and articulate pathways for therapies for advanced and complex Parkinson’s Disease.

The Scottish Medicines Consortium (SMC) assesses the clinical and cost- effectiveness of newly licensed medicines on a once for Scotland basis and publishes advice for Health Boards to consider. It is expected that Health Board Area & Drug and Therapeutics Committees (ADTCs) will consider making an SMC-recommended medicine, or an equivalent, available on their local or regional formulary for routine prescribing within 90 days of SMC advice being published.

Health Boards are expected to apply common principles and processes in the introduction of newly licensed medicines to facilitate consistency of approach to local decision-making. The decision to prescribe a medicine, and which medicine to prescribe, is entirely for the clinician in charge of a person’s care, having considered their clinical condition, their safety, and any relevant clinical guidance.

Decision-making on Scotland’s vaccination programme continues to be guided by the independent, expert advice of the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI currently advises flu vaccination for all those aged 65 years and over, along with individuals who have specific underlying health conditions.

Before the COVID-19 pandemic, the JCVI advised routine flu vaccination for those 65 years and over, as well as those with underlying health conditions. Scotland followed this advice.

Our programme was expanded during the pandemic in order to protect the people of Scotland, the NHS and the wider health and social care sector, while it was under severe COVID-related pressure. The programme was expanded to those aged 55 years and over in 2021, and then to those aged 50 years and over in 2022 and 2023.

In winter 2024, as we moved beyond the COVID-19 pandemic, we reverted to the standard JCVI-advised groups and those aged 50-64 years were no longer included. This is in line with JCVI advice, endorsed by Scotland’s Chief Medical Officer.